TGI Solar Power Group Inc (OTC:TSPG) Stock Extends Rally: Here is Why

Investors are often on the lookout for companies that are innovative in nature, and one such company that could be worth tracking at this point is TGI Solar Power Group Inc. (OTC:TSPG). On January 5, that company announced that, through its veterinary biotech company, BIOVET CGT, it had entered into a research and development agreement with the firm ELA Pharma.

The collaboration, which was described as strategic in nature, would be focused on the development of innovative cell death therapy treatments aimed at the veterinary industry. The news release further added that the collaboration between ELA Pharma and BIOVET would entail the utilization and development of intelligent, smart medical treatments. The basis of the treatments would be cell death therapy, a unique approach in the world of veterinary medicine. The collaboration is expected to lead to the development of new products, and all of that will be taken care of jointly by the two companies.

As per the provisions of the agreement, the management teams at BIOVET and ELA Pharma would come up with a plan of action. Both ELA and BIOVET would nominate a senior representative each who would be charged with managing the workings of the agreement. The final responsibility for client relationships would be with BIOVET. The Chief Executive Officer of BIOVET, Henry Val, spoke about the agreement and his excitement about the partnership.

He noted that the collaboration that was agreed upon with ELA Pharma marked an exciting moment for BIOVET as a company. He went on to note that the commitment of the company towards advancements in animal healthcare and well-being remained as strong as ever. He asserted that the latest partnership would help revolutionize the treatments that would be provided to animals. It could be a good idea to add the TGO Solar Power stock to your watch lists.